Journal list Promote Sponsor
verified SJR 0,232 · Q3 • database Scopus / SJR indexed
Journal of Opioid Management
United States · Weston Medical Publishing
workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Journal of Opioid Management

Journal of Opioid Management is a journal indexed in SJR in Medicine (miscellaneous) and Anesthesiology and Pain Medicine with an H index of 46. It has an SJR impact factor of 0,232 and it has a best quartile of Q3. It has an SJR impact factor of 0,232.

ISSN: 1551-7489
Publisher: Weston Medical Publishing
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,232 Q3
H-index 46
Acceptance rate pie_chart
32%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,232

H-index

46

Docs (year)

66

Docs 3y

201

Total refs

1543

Cites 3y

115

Citable 3y

193

Cites/Doc 2y

0.51

Ref/Doc

23.38

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis

View more

Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine-The Raffaeli Detoxification Model

View more

Comorbidities in an Australian sample of chronic and new opioid users

View more

Clinician opioid prescribing practices and patient utilization of prescribed opioids in pediatrics

View more

Clinical effectiveness and safety of OROS® hydromorphone in breakthrough cancer pain treatment: A multicenter, prospective, open-label study in Korean patients

View more

Characteristics of prior emergency departments visits associated with subsequent opioid overdose

View more

Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse

View more

Case Study. Transdermal buprenorphine controls central neuropathic pain

View more

Case study investigating effect of implementing strategies for Reducing patient complaints in an outpatient pain clinic

View more

Caregiver-fabricated illness in a child prescribed long-term opioids and benzodiazepines

View more

Beliefs and attitudes about prescribing opioids among healthcare providers seeking continuing medical education

View more

Aromatherapy as an adjunctive therapy for neonatal abstinence syndrome: A pilot study

View more
SHOW MORE ARTICLES

Analgesic treatment for moderate-to-severe acute pain in the United States: Patients' perspectives in the Physicians Partnering Against Pain (P3) Survey

View more

12-Month safety and effectiveness of once-daily hydrocodone

View more

An overview on medication-assisted treatment (MAT) for opioid dependence

View more

An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult

View more

An improved method of determining ethanol use in a chronic pain population

View more

An evaluation of the performance of the Opioid Manager clinical tool in primary care: A qualitative study

View more

Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain

View more

Activity-based cost analysis of opioid-related nausea and vomiting among inpatients

View more

A review of rapid-onset opioids for breakthrough pain in patients with cancer

View more

A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders

View more

A multicomponent intervention to improve adherence to opioid prescribing and monitoring guidelines in primary care

View more

A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain

View more

FAQs